annual EBIT:
-$301.15M-$78.09M(-35.01%)Summary
- As of today (August 29, 2025), ABCL annual earnings before interest & taxes is -$301.15 million, with the most recent change of -$78.09 million (-35.01%) on December 31, 2024.
- During the last 3 years, ABCL annual EBIT has fallen by -$523.04 million (-235.71%).
- ABCL annual EBIT is now -232.63% below its all-time high of $227.06 million, reached on December 31, 2022.
Performance
ABCL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$49.59M+$13.07M(+20.87%)Summary
- As of today (August 29, 2025), ABCL quarterly earnings before interest & taxes is -$49.59 million, with the most recent change of +$13.07 million (+20.87%) on June 1, 2025.
- Over the past year, ABCL quarterly EBIT has increased by +$43.87 million (+46.94%).
- ABCL quarterly EBIT is now -118.39% below its all-time high of $269.59 million, reached on March 31, 2022.
Performance
ABCL quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$278.66M+$43.87M(+13.60%)Summary
- As of today (August 29, 2025), ABCL TTM earnings before interest & taxes is -$278.66 million, with the most recent change of +$43.87 million (+13.60%) on June 1, 2025.
- Over the past year, ABCL TTM EBIT has dropped by -$9.37 million (-3.48%).
- ABCL TTM EBIT is now -165.94% below its all-time high of $422.62 million, reached on September 30, 2022.
Performance
ABCL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABCL EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -35.0% | +46.9% | -3.5% |
3 y3 years | -235.7% | -1456.3% | -181.5% |
5 y5 years | -10000.0% | -1566.3% | -9264.6% |
ABCL EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -232.6% | at low | -194.0% | +47.1% | -165.9% | +13.6% |
5 y | 5-year | -232.6% | at low | -118.4% | +47.1% | -165.9% | +13.6% |
alltime | all time | -232.6% | at low | -118.4% | +47.1% | -165.9% | +13.6% |
ABCL EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$49.59M(-20.9%) | -$278.66M(-13.6%) |
Mar 2025 | - | -$62.66M(-13.9%) | -$322.53M(+2.5%) |
Dec 2024 | -$301.15M(+35.0%) | -$72.75M(-22.3%) | -$314.77M(+2.2%) |
Sep 2024 | - | -$93.66M(+0.2%) | -$308.06M(+14.4%) |
Jun 2024 | - | -$93.45M(+70.2%) | -$269.29M(+18.5%) |
Mar 2024 | - | -$54.89M(-16.9%) | -$227.23M(-4.2%) |
Dec 2023 | -$223.05M(-198.2%) | -$66.05M(+20.3%) | -$237.21M(+14.4%) |
Sep 2023 | - | -$54.89M(+6.8%) | -$207.38M(+108.0%) |
Jun 2023 | - | -$51.39M(-20.8%) | -$99.72M(+93.6%) |
Mar 2023 | - | -$64.87M(+79.1%) | -$51.51M(-118.2%) |
Dec 2022 | $227.06M(+2.3%) | -$36.22M(-168.6%) | $282.95M(-33.0%) |
Sep 2022 | - | $52.77M(-1756.3%) | $422.62M(+23.7%) |
Jun 2022 | - | -$3.19M(-101.2%) | $341.75M(+0.1%) |
Mar 2022 | - | $269.59M(+160.6%) | $341.51M(+36.6%) |
Dec 2021 | $221.90M | $103.45M(-468.2%) | $250.01M(-25.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$28.10M(+720.8%) | $334.48M(-7.3%) |
Jun 2021 | - | -$3.42M(-101.9%) | $360.81M(-0.1%) |
Mar 2021 | - | $178.08M(-5.2%) | $361.26M(+97.2%) |
Dec 2020 | $164.34M(-8309.0%) | $187.92M(<-9900.0%) | $183.17M(-3961.7%) |
Sep 2020 | - | -$1.77M(-40.6%) | -$4.74M(+59.4%) |
Jun 2020 | - | -$2.98M(<-9900.0%) | -$2.98M(<-9900.0%) |
Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2019 | -$2.00M(-484.3%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2018 | $521.00K | - | - |
Dec 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2018 | - | $0.00 | $0.00 |
FAQ
- What is AbCellera Biologics Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual EBIT year-on-year change?
- What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
- What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM EBIT year-on-year change?
What is AbCellera Biologics Inc. annual earnings before interest & taxes?
The current annual EBIT of ABCL is -$301.15M
What is the all time high annual EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual earnings before interest & taxes is $227.06M
What is AbCellera Biologics Inc. annual EBIT year-on-year change?
Over the past year, ABCL annual earnings before interest & taxes has changed by -$78.09M (-35.01%)
What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ABCL is -$49.59M
What is the all time high quarterly EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly earnings before interest & taxes is $269.59M
What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
Over the past year, ABCL quarterly earnings before interest & taxes has changed by +$43.87M (+46.94%)
What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ABCL is -$278.66M
What is the all time high TTM EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM earnings before interest & taxes is $422.62M
What is AbCellera Biologics Inc. TTM EBIT year-on-year change?
Over the past year, ABCL TTM earnings before interest & taxes has changed by -$9.37M (-3.48%)